Therapeutic effect of dihydroartemisinin on Alzheimer’s disease model mice with senile macular degeneration

Therapeutic effect of dihydroartemisinin on Alzheimer’s disease model mice with senile macular degeneration

Abstract Objectives This study focuses on the preventive and therapeutic effects of Dihydroartemisinin (DHA) on Alzheimer’s disease (AD) model mice and the effects of DHA and donepezil on amyloid β-protein deposition and autophagy in nerve cells. Methods Six autophagy related targets were selected f...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gao Han, Gong Xuewu, Zhang Meng, Wang Yuejing, Wang Yuchun, Zhang Keshuang, Yao Hongbo
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Series:	European Journal of Medical Research
Subjects:	Alzheimer’s disease Age-related macular degeneration Dihydroartemisinin Amyloid β-protein deposition
Online Access:	https://doi.org/10.1186/s40001-025-02315-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mesenchymal stem cell‐derived exosomes mitigate amyloid β‐induced retinal toxicity: Insights from rat model and cellular studies
by: Amanda Qarawani, et al.
Published: (2025-01-01)

Understanding the Impact of the Sirtuin 1 (SIRT1) Gene on Age-related Macular Degeneration: A Comprehensive Study
by: Saranya Velmurugan, et al.
Published: (2024-04-01)

EFFICIENT RETINAL IMAGE SEGMENTATION BY U-NET FOR AGE-RELATED MACULAR DEGENERATION DIAGNOSIS
by: S Sujatha, et al.
Published: (2024-12-01)

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
by: Cyrus Jalili, et al.
Published: (2023-05-01)

Ibuprofen reduces inflammation, necroptosis and protects photoreceptors from light-induced retinal degeneration
by: Ping-Wu Zhang, et al.
Published: (2025-01-01)

A cross-tissue transcriptome-wide association study identified susceptibility genes for age-related macular degeneration
by: Hongfan Yang, et al.
Published: (2025-02-01)

Could Infectious Agents Play a Role in the Onset of Age-related Macular Degeneration? A Scoping Review
by: Petra P. Larsen, MD, PhD, et al.
Published: (2025-03-01)

Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration
by: Lucas Stürzbecher, et al.
Published: (2025-02-01)

Patients with Age-related Macular Degeneration Have Increased Susceptibility to Valvular Heart Disease
by: Natan Lishinsky-Fischer, et al.
Published: (2025-03-01)

Effects of dietary dihydroartemisinin on growth performance, meat quality, and antioxidant capacity in broiler chickens
by: Xiaoxiao Pu, et al.
Published: (2025-01-01)

Structural Analysis of Amylin and Amyloid β Peptide Signaling in Alzheimer’s Disease
by: Longsheng Xie, et al.
Published: (2025-01-01)

Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
by: Kumju Youn, et al.
Published: (2022-05-01)

Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
by: Tapas K. Sur, et al.
Published: (2025-06-01)

Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents
by: Hongtao Du, et al.
Published: (2025-01-01)

Opportunities, challenges, and difficulties in NMR-based metabolomics applied to neovascular age-related macular degeneration (nAMD) patient follow-up
by: M. Schoumacher, et al.
Published: (2025-01-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

Degradation of amyloid β-peptides catalyzed by nattokinase in vivo and in vitro
by: Aixin Ni, et al.
Published: (2023-09-01)

The antioxidant potential of bacoside and its derivatives in Alzheimer's disease: The molecular mechanistic paths and therapeutic prospects
by: Dipanjan Karati, et al.
Published: (2025-06-01)

Modeling pegcetacoplan treatment effect for atrophic age-related macular degeneration with AI-based progression prediction
by: Irmela Mantel, et al.
Published: (2025-02-01)

Diagnosis and Treatment of Alzheimer’s Disease: Current Update
by: Younghee Yim, et al.
Published: (2025-01-01)

Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer’s disease by regulating microglia homeostasis and inhibiting HMGB1 pathway
by: Yuan Xu, et al.
Published: (2025-02-01)

Predictive value of different baseline optical coherence tomography biomarkers for visual acuity changes in neovascular age-related macular degeneration
by: Hamid Riazi-Esfahani, et al.
Published: (2025-02-01)

Dihydroartemisinin inhibits EphA2/PI3K/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells
by: Huangde Fu, et al.
Published: (2025-02-01)

Assessment of retinal pigment epithelium tears in eyes with submacular hemorrhage secondary to age-related macular degeneration
by: Tomoko Ueda-Consolvo, et al.
Published: (2025-01-01)

Abca4, mutated in Stargardt disease, is required for structural integrity of cone outer segments
by: John J. Willoughby, et al.
Published: (2025-01-01)

The amplitude of low frequency fluctuation and spontaneous brain activity alterations in age-related macular degeneration
by: Yan Yan Zhang, et al.
Published: (2025-01-01)

Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease
by: Arif Malik, et al.
Published: (2025-02-01)

Machine learning models for dementia screening to classify brain amyloid positivity on positron emission tomography using blood markers and demographic characteristics: a retrospective observational study
by: Noriyuki Kimura, et al.
Published: (2025-01-01)

Co-Localized in Amyloid Plaques Cathepsin B as a Source of Peptide Analogs Potential Drug Candidates for Alzheimer’s Disease
by: Marilena K. Theodoropoulou, et al.
Published: (2024-12-01)

Targeting Soluble Amyloid Oligomers in Alzheimer’s Disease: A Hypothetical Model Study Comparing Intrathecal Pseudodelivery of mAbs Against Intravenous Administration
by: Manuel Menendez-Gonzalez
Published: (2025-01-01)

Acceptability of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in Papua New Guinea: a qualitative study
by: Elvin Lufele, et al.
Published: (2025-01-01)

Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge
by: Shahram Darabi, et al.
Published: (2025-06-01)

Intraocular inflammation after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration: a case report
by: Nozomu Hashiya, et al.
Published: (2025-01-01)

A comprehensive review on early detection of drusen patterns in age-related macular degeneration using deep learning models
by: Kiruthika M, et al.
Published: (2025-02-01)

Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
by: Hayder M. Al-Kuraishy, et al.
Published: (2025-02-01)

Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies
by: Androulla N. Miliotou, et al.
Published: (2025-01-01)

Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
by: Jimin Kim, et al.
Published: (2025-01-01)

In search of Alzheimer’s disease treatment methods: trends of clinical trials
by: G. Pakulaitė, et al.
Published: (2018-03-01)

Multi-functional role of apolipoprotein E in neurodegenerative diseases
by: Sadequl Islam, et al.
Published: (2025-01-01)

Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives
by: Byeong-Hyeon Kim, et al.
Published: (2025-01-01)